Results 351 to 360 of about 308,094 (362)
Some of the next articles are maybe not open access.

Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα

Annals of the Rheumatic Diseases, 2008
Objective: To evaluate the effect in mice with arthritis of active anti-TNFα immunotherapy based on a keyhole limpet hemocyanin-human TNFα heterocomplex (hTNFα kinoid or TNFK) adjuvanted in incomplete Freund adjuvant. Immunotherapy was evaluated also with methotrexate.
Delavallée, Laure   +7 more
openaire   +1 more source

Therapeutic pathomorphism of non-small cell lung cancer (NSCLC) as a result of neoadjuvant chemoimmunotherapy (nCIT) with tumor necrosis factor (TNFα1).

Journal of Clinical Oncology, 2018
e24323Background: The purpose of the study was to reveal morphological changes in tissues of NSCLC after various nPCT regimens.
Yuri Lazutin   +13 more
openaire   +1 more source

Protective role of nitric oxide in the TNFα-mediated hepatic microvascular inflammatory response following acute ethanol ingestion

Hepatology Research, 2000
Abstract Gut-drived endotoxin is thought to be involved in the pathogenesis of alcoholic liver disease. Nitric oxide (NO) has a protective function in attenuating hepatic injury elicited by endotoxin and is suspected to play a role in the hepatic microvascular responses induced following alcohol ingestion. As a result, the role of NO and the possible
openaire   +1 more source

Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey.

Journal of immunotherapy, 2019
Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and warrant anti-tumor necrosis factor α (TNFα) treatment in severe forms.
C. Lesage   +15 more
semanticscholar   +1 more source

Disseminated tuberculosis after anti-TNFα therapy for Crohn\'s disease

2015
Clinical History: Patient with long-standing history of Crohn’s disease (CD) including partial colectomy, treated with adalimumab for four months due to steroid-refractory disease. Currently hospitalized with malaise, weight loss, mucohaemorrhagic diarrhoea, persistent h...
openaire   +1 more source

Lysyl Oxidase is a Novel Fibrostenotic Indicator in Eosinophilic Esophagitis Induced VIA the TNFΑ-TGFÎ' Axis in the Epithelial-Fibroblast Crosstalk

Gastroenterology, 2017
Yuta Kasagi   +12 more
openaire   +1 more source

The Fecal Microbiome as a Tool for Monitoring and Predicting Response Outcomes in Ustekinumab-Treated, Anti-TNFî‘ Refractory Crohn’s Disease Patients: Results from the Certifi Study

Gastroenterology, 2017
Matthew K. Doherty   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy